Shenzhen Center for Chronic Disease Control
8
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform
Role: collaborator
Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes
Role: collaborator
Health and Nutrition Survey on Shenzhen Children
Role: lead
Bioavailability of Iodine for Natural Kelp and Iodized Salt in Young Adults
Role: collaborator
VDR SNPs & 25OHD Correlated With Dyslipidemia
Role: lead
Micronutrients and Health in Adult Chinese
Role: lead
Observational Study on a Chinese Population
Role: lead
Vitamin D Supplementation to Obese Chinese Males
Role: lead
All 8 trials loaded